What is Eton Pharmaceuticals, Inc.'s EV / EBITDA?

Eton Pharmaceuticals, Inc. (ETON) reported EV / EBITDA of 525.2× in Q2 2025.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Eton Pharmaceuticals, Inc. ETON EV / EBITDA

EV / EBITDA at other companies

HRO

HarrowHROW

70.8×-139×

Zevra Therapeutics, Inc.ZVRA

171.7×—

XER

Xeris Biopharma Holdings, Inc.XERS

30.8×—

ANI PharmaceuticalsANIP

8.1×-16.2×

Catalyst PharmaceuticalCPRX

7.4×-1.4×

Neurocrine BiosciencesNBIX

16.4×-5.2×

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+156%

Enterprise value$942.39M+150%

P/S10.7×+3.2×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

enterprise value/ebitda=525.2×

Based on the most recent quarter.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s EV / EBITDA?: Eton Pharmaceuticals, Inc. (ETON) reported EV / EBITDA of 525.2× in Q2 2025.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.